MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers

ROOT OF SKIN™ Skincare Line Sells Out at Product Launch on QVC Japan

AIVITA Biomedical Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial

AIVITA Biomedical to Exhibit ROOT OF CANCER Immunotherapy at 33rd SITC Annual Meeting

AIVITA Biomedical Consumer Skincare Line ROOT OF SKIN™ to Be Sold on Home Shopping Channel QVC Japan

AIVITA Biomedical Enrolls First Patient in Phase 2 Glioblastoma Trial

AIVITA Biomedical Appoints Paul Jenkinson and Philippe Schaison to its Board of Directors

AIVITA Biomedical Attains Japanese PMDA Milestone for ROOT OF CANCER Technology

AIVITA Biomedical Announces Treatment of First Patient in Phase 2 Ovarian Cancer Trial

AIVITA Biomedical Appoints Chief Financial Officer and Vice President of Business Development

AIVITA Biomedical Announces Initiation of First Clinical Site for ROOT OF CANCER Glioblastoma Trial

  • Previous
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next

AIVITA Biomedical is a biotechnology company developing personalized vaccines that target infectious diseases and tumor-initiating cells — the seed of all cancers — using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development in cancer, infectious disease and other fields.

Recent News

  • AIVITA Biomedical Licenses Novel Skincare Formulations to Global Skincare Retailer LevEllis
  • AIVITA Biomedical CEO Dr. Hans Keirstead and CMO Dr. Robert Dillman to Speak and Participate in Keynote Panel at Festival of Biologics USA
  • AIVITA Biomedical CEO Dr. Hans Keirstead to Join Keynote Panel for AI in Public Health at World Vaccine Congress
  • AIVITA Biomedical Strengthens Board of Directors with Appointment of Ex-Biogen CEO Michel Vounatsos
  • AIVITA Biomedical CEO Dr. Hans Keirstead to Present at Biotech Showcase 2024

Site Navigation

  • About Us
  • Programs
  • News & Media
  • Contact Us
Copyright © 2023 | AIVITA Biomedical, Inc.